Adverum Biotechnologies Inc [NASDAQ: ADVM] closed the trading session at $1.65. The company report on March 18, 2024 at 4:05 PM that Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate Updates. – Preliminary LUNA data presented
Adverum Biotechnologies Inc [NASDAQ: ADVM] plunged by -$0.1 during the normal trading session on while it closed the day at $2.00. The company report on February 12, 2024 at 8:00 AM that Adverum Biotechnologies to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference.
Adverum Biotechnologies Inc [NASDAQ: ADVM] jumped around 0.49 points on Monday, while shares priced at $1.91 at the close of the session, up 34.51%. The company report on February 5, 2024 at 7:45 AM that Adverum Biotechnologies Announces $127.5 Million Private Placement Financing. – Financing
© 2024, Powered by Smart TechOne
